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BACKGROUND AND PURPOSE: Stroke remains the third most common cause of death in industrialized na-
tions, and the single most common reason for permanent disability. Intravenous thrombolysis with recombi-
nant tissue plasminogen activator (rtPA, Alteplase) for the treatment of acute ischemic stroke within 3 hours of
onset become, a worldwide conventional standard of care. Thrombolytic stroke therapy is based on the
"recanalization hypothesis," that reopening of occluded vessels improves clinical outcome in acute ischemic
stroke through regional reperfusion and salvage of threatened tissues. However, intravenous thrombolysis is
successful in approximately one third of patients. Thromboaspiration through either a microcatheter, or a guid-
ing catheter may be an option for a fresh nonadhesive clot. The use of mechanical thrombectomy devices in pa-
tients experiencing ischemic stroke and reoclusion after intravenous thrombolysis can now gain approval on the
basis of recanalization. CASE DESCRIPTION: We describe a case of a 51-year-old man who presented with
ischemic stroke (right-sided hemiparesis and sensomotor aphasia) and sudden onset on 06.50h. He was hospita-
lised in Neuro intensive Care Unit on 08.10h with NIHSS 8 points. The CT of the head was normal and on 8.40h.
began a intravenous rtPa by protocol: body weight 70 kg õ 0,9 mg rtPA- 63 mg ACTILYSE with 10% bolus and
i.v infusion for 60 min. After beginning it was a significant improvement with neurological deficite NIHSS 5
points. After the end of the fibrinolysis the patient was with severe deterioration of the symtoms (right-sided
hemiplegia and aphasia) - NIHSS 15 points. The patient underwent control CT of the head to exclude
intracerebral haemorrhage - was normal. On the digital subtraction angiography there was total thrombosis of
the left internal carotid artery. Through a guiding catheter was done thrombo aspiration with effective
reperfusion with reversal of neurological deficits - NIHSS 3 points. CONCLUSIONS: This case represents a
valuable example of two recanalization therapies in acute ischemic stroke to improve clinical outcome by restor-
ing anterograde perfusion and salvaging ischemic brain.
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Ischemia in the brain may result from diverse mechanisms,
although blockage of an artery with a clot or progressive
narrowing due to atherosclerosis is the most common. Such
occlusions in proximal arteries at the base of the brain may
be targeted with numerous revascularization approaches,
from systemic thrombolysis to endovascular clot manipula-
tion, in order to restore perfusion. Revascularization re-
mains the most intuitive strategy to reverse ischemic injury
associated with arterial occlusion in acute stroke.
Revascularization may lead to opening of an occluded ar-
tery, or recanalization, yet restoration of downstream flow,
or reperfusion, may not ensue. The potential role of intrave-
nous thrombolysis for recanalization of various occlusion
sites has also been examined in depth (5). In the Echoplanar
Imaging Thrombolytic Evaluation Trial, intravenous tissue
plasminogen activator administered in the 3- to 6-hour time
window showed poor recanalization of intracranial carotid
artery (ICA) lesions and far better results with middle cere-
bral artery (MCA) occlusions (5). The treatment benefit of
tissue plasminogen activator over placebo in limiting in-
farct evolution was greater for MCA than for ICA obstruc-
tion (P =0.060). Good clinical outcome was also more
likely with MCA than with ICA occlusion (P =0.005). It
should be noted that these definitions were based on
noninvasive magnetic resonance angiography. This pattern
of better recanalization in MCA lesions was observed in
univariate analyses of another study that looked at occur-
rence and predictors of futile endovascular recanalization
(6). Interestingly, however, the role of occlusion site disap-
peared in multivariate regression in which only age and
baseline stroke severity were influential in predicting failed
recanalization (6). Perhaps the extent of early ischemic
changes in baseline imaging may be influential, as well (7).
Patients with a baseline NIHSS score of 10-19 may in fact
be ideal candidates for endovascular interventions if the pa-
tients have small cores with proximal occlusions.
Accurate predictors of recanalization may be important in
endovascularprocedures and knowing when to cease attempts
at opening an artery. Such limitations with novel devices must
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be considered as new technology and methods are introduced.
A recent report on the use of the Enterprise stent. Another
study demonstrated appropriately defined reperfusion success,
treated with the Solitaire stent (EV3 Inc., USA).
Following revascularization, reperfusion more accurately
predicts infarct growth than recanalization does (14). Fu-
ture interventions, such as decompressive
hemicraniectomy, may be used after failed reperfusion.
This surgery is currently reserved for life-threatening mas-
sive infarcts, yet one group suggested that it may be used at
an earlier stage or pre-emptively or as early as possible in
cases of failed multimodal therapy. Revascularization strat-
egies and novel devices continue to broaden options for the
treatment of acute stroke, but it is increasingly apparent that
selection criteria to identify ideal cases are needed to refine
triage and minimize adverse events.. Finally, it should not
be forgotten that clinical outcome is ultimately what mat-
ters most. Randomized controlled studies have yet to un-
equivocally demonstrate that novel revascularization and
prompt reperfusion impact outcome.
Case Description
We describe a case of a 51-year-old man who presented
with ischemic stroke (right-sided hemiparesis and
sensomotor aphasia) and sudden onset on 06.50h. The pa-
tient has Dibetes mellitus type ²² from 5 years with good
control without treatment and arterial hypertension, treated
with ACE-inhibitor.
He was hospitalised in Neuro intensive Care Unit of Sec-
ond Clinic of Neurology on 08.10h with NIHSS 8 points.
On Doppler sonography before the treatment it was high
grate stenosis of the left internal carotid artery (fig. 1).
The CT of the head was normal and on 8.40h. began a in-
travenous rtPa by protocol: body weight 70 kg õ 0,9 mg
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Fig. 1. Doppler sonography of left carotid artery – high grate stenosis
Fig. 2. CT of the head
rtPA- 63 mg ACTILYSE with 10% bolus and i.v infusion
for 60min (fig. 2).
After beginning it was a significant improvement with neu-
rological deficite NIHSS 5 points. After the end of the
fibrinolysis the patient was with severe deterioration of the
symtoms (right-sided hemiplegia and aphasia) - NIHSS 15
points. The patient underwent control CT of the head to ex-
clude intracerebral haemorrhage - was normal (fig. 3).
On digital subtraction angiography, made on 10.40h it was
total thrombosis of the stenotic segment of the left internal
carotid artery (fig. 4A).
After aspiration of the thrombus trough the guiding catheter
with 50 cc syringe and stanting on 11.32h, the flow was
restorated (fig. 4A, 4C, fig.5).
CONCLUSIONS
Revascularization remains the most intuitive strategy to re-
verse ischemic injury associated with arterial occlusion in
acute stroke. Revascularization may lead to opening of an
225
Andonova S., F. Kirov, Ch. Bachvarov
Fig. 3. Control CT (10.15 h) to exclude intracerebral haemorrhage NIHSS = 15
Fig. 4. Digital subtraction angiography A - thrombosis of the left internal carotid artery; B - after thromboaspiration
and C - stent with effective reperfusion
Fig.5. Intracranial teritory of left carotid artery after
fibrinolysis and stenting
occluded artery, or recanalization, yet restoration of down-
stream flow, or reperfusion, may not ensue.
Revascularization strategies and novel devices continue to
broaden options for the treatment of acute stroke, but it is
increasingly apparent that selection criteria to identify ideal
cases are needed to refine triage and minimize adverse
events. The results of recent work on reperfusion may rap-
idly alter routine clinical practice for evolving ischemia in
the brain.
This case represents a valuable example of two
recanalization therapies in acute ischemic stroke to im-
prove clinical outcome by restoring anterograde perfusion
and salvaging ischemic brain.
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